Locally Advanced or Metastatic Urothelial Bladder Cancer — Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer
Citation(s)
A Single-Arm, Multicenter Phase 2 Study of BGB-A317 in Patients With Previously Treated PD-L1+ Locally Advanced or Metastatic Urothelial Bladder Cancer